Biovie Inc (BIVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,977 | 13,099 | 20,541 | 24,978 | 17,545 |
| Receivables | 2,151 | 2,174 | 196 | 180 | 2,104 |
| Other current assets | 2,513 | 1,607 | 1,055 | 874 | 1,050 |
| TOTAL | $13,642 | $16,880 | $21,791 | $26,032 | $20,699 |
| Non-Current Assets | |||||
| Intangibles | 346 | 352 | 409 | 467 | 524 |
| Other Non-Current Assets | 263 | 283 | 303 | 321 | 340 |
| TOTAL | $608 | $635 | $712 | $788 | $864 |
| Total Assets | $14,251 | $17,515 | $22,503 | $26,820 | $21,562 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,705 | 1,611 | 2,923 | 1,566 | 2,200 |
| TOTAL | $3,796 | $1,694 | $3,006 | $1,645 | $2,275 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 184 | 213 | 233 | 254 | 275 |
| TOTAL | $184 | $213 | $233 | $254 | $275 |
| Total Liabilities | $3,980 | $1,907 | $3,238 | $1,899 | $2,550 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,543 | 7,542 | 7,544 | 7,540 | 7,534 |
| Common Shares | 1 | 1 | 1 | 1 | 0 |
| Retained earnings | -374,261 | -368,615 | -363,345 | -357,275 | -352,144 |
| TOTAL | $10,270 | $15,608 | $19,265 | $24,921 | $19,012 |
| Total Liabilities And Equity | $14,251 | $17,515 | $22,503 | $26,820 | $21,562 |